Ataraxis AI: $20.4 Million (Series A) Raised For Transforming Precision Medicine In Cancer Care
By Amit Chowdhry ● Mar 12, 2025
Ataraxis AI, a leading AI precision medicine company, announced its $20.4 million Series A financing led by AIX Ventures with participation from Floating Point, Thiel Bio, Founders Fund, Bertelsmann Investments, and existing investors Giant Ventures and Obvious Ventures. The funding round also received backing from angel investors and healthcare pioneers, including Mario Schlosser (co-founder and former CEO of Oscar Health) and Ryan Fukushima (COO of Tempus), and others. And leading researchers from OpenAI and DeepMind also participated.